Abstract
Liver toxicity has been one of the major causes for drug attrition. It has caused discontinuation of preclinical and clinical studies, and withdrawals and black box warnings of marketed drugs. Drug-induced hepatotoxicity may lead to organ failure and, ultimately, patient death. Understandably, liver toxicity is one of the most important issues in the drug development cycle. In silico models based on chemical structure provide a cost effective approach for hepatotoxicity, and it can help prioritize lab tests, preclinical and clinical studies. There is no doubt as to the need for predictive methods in every stage of the drug discovery pipeline. However there is a serious shortage of consistent data for the development of reliable models and developing genuinely predictive models for hepatotoxicity remains a challenge.
Current Computer-Aided Drug Design
Title: In Silico Prediction of Hepatotoxicity
Volume: 5 Issue: 2
Author(s): Ailan Cheng
Affiliation:
Abstract: Liver toxicity has been one of the major causes for drug attrition. It has caused discontinuation of preclinical and clinical studies, and withdrawals and black box warnings of marketed drugs. Drug-induced hepatotoxicity may lead to organ failure and, ultimately, patient death. Understandably, liver toxicity is one of the most important issues in the drug development cycle. In silico models based on chemical structure provide a cost effective approach for hepatotoxicity, and it can help prioritize lab tests, preclinical and clinical studies. There is no doubt as to the need for predictive methods in every stage of the drug discovery pipeline. However there is a serious shortage of consistent data for the development of reliable models and developing genuinely predictive models for hepatotoxicity remains a challenge.
Export Options
About this article
Cite this article as:
Cheng Ailan, In Silico Prediction of Hepatotoxicity, Current Computer-Aided Drug Design 2009; 5 (2) . https://dx.doi.org/10.2174/157340909788451883
DOI https://dx.doi.org/10.2174/157340909788451883 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Pathophysiology of Uric Acid in Relation to Cardiovascular Disease
Current Cardiology Reviews Patents in the Diagnosis and Therapy of Neurocardiogenic Syncope
Recent Patents on Cardiovascular Drug Discovery Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker
Current Molecular Medicine Pregnancy and Sleep Apnea
Current Respiratory Medicine Reviews Detection and Treatment of Alcohol-Induced Hypertension
Current Hypertension Reviews Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?
Current Vascular Pharmacology Metaboloepigenetics: The Emerging Network in Stem Cell Homeostasis Regulation
Current Stem Cell Research & Therapy In Vivo Optical Imaging in Gene & Cell Therapy
Current Gene Therapy Renal Microcirculation and Calcium Channel Subtypes
Current Hypertension Reviews Strategies to Tackle Early Low Flow States in the Extremely Preterm Infant
Current Pediatric Reviews Pulmonary Hypertension and Systemic Diseases
Current Drug Targets - Inflammation & Allergy Epidural Analgesia in the Post-Anaesthesia Care Unit
Current Drug Targets Effects of Hypertension, Diabetes Mellitus, Obesity and Other Factors on Kidney Haemodynamics
Current Vascular Pharmacology Spontaneous Pneumothorax
Current Respiratory Medicine Reviews Image-based Computational Fluid Dynamics: A New Paradigm for Monitoring Hemodynamics and Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders P-glycoprotein Inhibition: The Past, the Present and the Future
Current Drug Metabolism Hypertension in Peripheral Arterial Disease
Current Pharmaceutical Design Fetal Cardiac Cellular Damage Caused by Anemia in Utero in Hb Bart’s Disease
Current Molecular Medicine A Review on Recent Patents in Digital Processing for Cardiac Electric Signals (I): From Basic Systems to Arrhythmia Analysis
Recent Patents on Biomedical Engineering (Discontinued)